Table 1.
Candidate makers of cardioembolic stroke.
Name | Type of Biomarker | Protein Accession # | Sample size | Protein Levels Regarding Etiology | Main Function | Ref |
---|---|---|---|---|---|---|
Albumin | Protein | P02768 | 200 | CE < other etiologies | Regulates colloidal osmotic pressure of blood. | [52] |
ANP | Protein | P01160 | 262 | CE > other etiologies | Cardiovascular homeostatic hormone. | [32] |
BNP | Protein fragment | - | 1300 | CE > other etiologies | ProBNP cleavage product. Cardiac hormone that regulates cardiovascular homeostasis. | [24, 29, 31, 39] |
CK-MB | Protein | P12277-P06732** | 262 | CE > other etiologies | Mediates energy transduction in tissues. Increased in heart damage diseases. | [32, 39] |
CRP* | Protein | P02741 | 985 | CE > other etiologies; LAA > other etiologies; no difference among subtypes | Displays several functions associated with host defense. Risk marker of AF. | [49-54, 59] |
D-dimer | Protein fragment | - | 1430 | CE > other etiologies | Fibrin degradation product. | [22-26, 52, 59, 60] |
FDP | Group of proteins | - | 69 | CE > non-CE | Involved in coagulation/fibrinolysis processes. | [26] |
Fibrinogen* | Protein | P02671 | 269 | CE < LAA; no difference among subtypes | Yields monomers that polymerize into fibrin and is a cofactor in platelet aggregation. | [25, 26] |
FMC | Protein aggregate | - | 69 | CE > non-CE | Involved in coagulation/fibrinolysis processes. | [26] |
IL-1β | Protein | P01584 | 227 | CE > other etiologies | Pro-inflammatory cytokine. | [33, 40] |
IL-6 | Protein | P05231 | 227 | CE > other etiologies | Pro-inflammatory cytokine. | [33, 40] |
NT-proBNP | Protein fragment | - | 92 | CE > non-CE | Pro-BNP cleavage product. High levels may help to select stroke patients with AF. | [27] |
Pro-BNP | Protein | P16860 | 262 | CE > other etiologies | BNP precursor. ProBNP might be useful to reclassify undetermined stroke as of CE origin. | [32] |
S100B | Protein | P04271 | 33 | CE > other etiologies | Involved in metal-ion binding and in the regulation of protein phosphorylation in brain tissue. | [61] |
sCD40L* | Protein | P29965 | 132 | No difference among etiologies | Inflammatory marker. Elevated in AF patients. | [62, 63] |
SF | Protein complex | - | 69 | CE > other etiologies | Involved in coagulation/fibrinolysis processes. | [26] |
sRAGE | Protein | Q9UQ07 | 1189 | CE > other etiologies | Growth factor for several cell types. | [24,55] |
TNF-α | Protein | P01375 | 227 | CE > other etiologies | Pro-inflammatory cytokine. | [33,40] |
vWF | Protein | P04275 | 1551 | CE and LAA > other etiologies | Promotes platelet adhesion to the sub-endothelial matrix. Higher in patients with AF. | [33-38] |
ANP: atrial natriuretic peptide; AF: atrial fibrillation; BNP: b-type natriuretic peptide; CE: cardioembolic; CK-MB: creatine kinase MB; CRP: C-reactive protein; FDP: fibrin/ fibrinogen degradation products, FMC: fibrin monomer complex; IL-1β: interleukin 1-beta; IL-6: interleukin 6; LAA: large artery atherosclerosis; ; NT-proBNP: N-terminal part of pro-BNP; Pro-BNP: proform of BNP; SF: soluble fibrin; sRAGE: soluble receptor for advanced glycation end products; SVD: small vessel disease; TNF-α: tumour necrosis factor alpha;
Candidate marker with controversial results among studies.
UniProt codes from CK-MM and CK-BB.